EXOBIO Trademark

Trademark Overview


On Thursday, February 22, 2024, a trademark application was filed for EXOBIO with the United States Patent and Trademark Office. The USPTO has given the EXOBIO trademark a serial number of 79392606. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 8, 2025. This trademark is owned by EXO Biologics. The EXOBIO trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Advanced medical therapy services by using medical products; extracellular medical therapy services; exosome medical therapy services; exosome medical treatment services; extracellular medical treatment services; none of the aforesaid services in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software.

Biotechnological research and development; extracellular research and development for therapies; exosome research and development for therapies; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software
exobio

General Information


Serial Number79392606
Word MarkEXOBIO
Filing DateThursday, February 22, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, April 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2025

Trademark Statements


Goods and ServicesAdvanced medical therapy services by using medical products; extracellular medical therapy services; exosome medical therapy services; exosome medical treatment services; extracellular medical treatment services; none of the aforesaid services in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software.
Goods and ServicesBiotechnological research and development; extracellular research and development for therapies; exosome research and development for therapies; none of the aforesaid services being for use in relation to ultrasound-based medical, diagnostic or therapeutic imaging apparatus or devices used for medical, diagnostic or therapeutic imaging and related software

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 1, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 1, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEXO Biologics
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressLiège B-4000
BE

Party NameEXO Biologics
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressLiège B-4000
BE

Trademark Events


Event DateEvent Description
Friday, April 5, 2024APPLICATION FILING RECEIPT MAILED
Friday, August 23, 2024LIMITATION OF GOODS RECEIVED FROM IB
Thursday, March 28, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, April 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 11, 2024ASSIGNED TO EXAMINER
Monday, September 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, September 17, 2024REFUSAL PROCESSED BY MPU
Tuesday, September 17, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 17, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 10, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 10, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 20, 2024LIMITATION OF GOODS RECEIVED FROM IB
Monday, October 7, 2024REFUSAL PROCESSED BY IB
Thursday, February 6, 2025LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Monday, March 10, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 11, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 2, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 17, 2025TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, April 4, 2025LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Tuesday, April 8, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 8, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED